Exclusive special offer and discount title banner vector image

NORTH AMERICA BOTULINUM TOXIN MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

North America Botulinum Toxin Market by Type (Type A Botulinum Toxin, Type B Botulinum Toxin) Market by User Demographic (Women, Men) Market by Application (Medical (Chronic Migraine, Muscle Spasm, Overactive Bladder, Hyperhidrosis, Other Medical Applications), Aesthetic (Crow’s Feet, Forehead Lines, Frown Lines/glabellar, Square Jaw/masseter, Other Aesthetic Applications)) Market by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users) by Geography


MARKET OVERVIEW

The North America botulinum toxin market is estimated to generate $7866.76 million in revenue by 2032, and is expected to surge with a 10.10% CAGR during the forecast period, 2023-2032.

The North American botulinum toxin industry is being driven by increasing demand for cosmetic procedures and growing research and development efforts to broaden the therapeutic uses of botulinum and address various diseases. The American Society of Plastic Surgeons reported that in 2019, 1.3 million operations with botulinum toxin-based products were carried out, accounting for 45% of all cosmetic procedures in the United States. In addition, per capita disposable income in the United States was $45,579, according to data published by the United States Bureau of Economic Analysis in 2019. These factors are expected to contribute significantly to the North America botulinum toxin market growth.

To Know More About This Report, Request a Free Sample Copy

The North America botulinum toxin market growth analysis evaluation entails a thorough study of Canada and the United States. Over the last two decades, medical aesthetic technology has advanced rapidly in the United States, offering patients a wide range of products and solutions. In 2019, according to the American Society for Aesthetic Plastic Surgery, 1,712,994 procedures were performed with botulinum toxin, with an injection to treat facial wrinkles considered the country’s most frequently performed cosmetic procedure. Therefore, the use of botulinum toxins in aesthetic medicine has significantly increased. 

Botulinum toxin injections are approved by the United States Food and Drug Administration for treating frown lines, crow’s feet, and horizontal forehead lines and are associated with high patient satisfaction and few adverse effects. In 2019 Daewoong Pharmaceutical launched Nabota, its botulinum toxin strain, becoming the first South Korean botulinum toxin product sold in the United States market. These approvals and launches have contributed to the overall growth of the market.

The North America botulinum toxin market segmentation assessment includes user demographic, application, end-user, and type. Market by user demographic covers women and men.

The women’s market dominates the global market for botulinum toxin, and it is predicted to continue growing during the forecast period. This is due to the increasing trend among middle-aged women for skin rejuvenation and aesthetic surgeries. In 2020, more than 4.1 million women received botulinum toxin surgery, according to data from the Aesthetic Society. Additionally, women experience visible signs of aging, such as forehead wrinkles, frown lines, and crow’s feet, which can be reduced with products containing botulinum toxin.

The desire for a more youthful appearance drives the growing interest in cosmetic treatments, particularly among women over 40 in developed nations. The market for botulinum toxin is expected to expand due to this trend. In 2020, more than 2.5 million women between the ages of 40 and 54 received botulinum toxin treatments worldwide, indicating significant potential for market growth. Therefore, the increased focus on aesthetic appearances, such as lip treatments for women, particularly in developed countries, is expected to fuel the expansion of the market.

Major market players in the North America botulinum toxin market include Revance Therapeutics Inc, AbbVie Inc, etc.

AbbVie Inc is a global biopharmaceutical company developing innovative drugs for complex and chronic diseases. The company’s robust pipeline includes treatments for women’s health, cystic fibrosis, various cancers, neurological disorders, and autoimmune diseases. AbbVie markets its products directly to healthcare facilities, government agencies, specialty pharmacies, and independent retailers worldwide through its distribution centers and warehouses. The company is headquartered in Illinois, United States. 

BOTOX, one of AbbVie’s products, is a highly effective treatment for various medical conditions, including adult bladder dysfunction, chronic migraine, spasticity, blepharospasm, and strabismus. The injection, administered intramuscularly, intradetrusor or intradermally, contains onabotulinumtoxinA and is widely used by healthcare professionals globally. With its proven efficacy, BOTOX has become popular for patients seeking relief from various medical conditions.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Type, User Demographic, Application, and End-User
Countries AnalyzedThe United States and Canada
Companies Analyzed

AbbVie Inc, Candela Medical, Daewoong Pharmaceutical 

Co Ltd, Evolus Inc, Galderma, Hugel Inc, Ipsen, Lanzhou Institute of Biological Products Co Ltd, Medytox, Merz Pharma, Revance Therapeutics Inc, US WorldMeds LLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    5. MAJOR MARKET FINDINGS
      1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
      2. GROWING AWARENESS ABOUT ‘NOTOX’
      3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
      2. RISING GERIATRIC POPULATION
      3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES 
    2. KEY RESTRAINTS
      1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY TYPE
    1. TYPE A BOTULINUM TOXIN
    2. TYPE B BOTULINUM TOXIN
  6. MARKET BY USER DEMOGRAPHIC
    1. WOMEN
    2. MEN
  7. MARKET BY APPLICATION
    1. MEDICAL
      1. CHRONIC MIGRAINE
      2. MUSCLE SPASM
      3. OVERACTIVE BLADDER
      4. HYPERHIDROSIS
      5. OTHER MEDICAL APPLICATIONS
    2. AESTHETIC
      1. CROW’S FEET
      2. FOREHEAD LINES
      3. FROWN LINES/GLABELLAR
      4. SQUARE JAW/MASSETER
      5. OTHER AESTHETIC APPLICATIONS
  8. MARKET BY END-USER
    1. SPECIALTY AND DERMATOLOGY CLINICS
    2. HOSPITALS AND CLINICS
    3. OTHER END-USERS
  9. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
      3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
      4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. ABBVIE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. CANDELA MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. DAEWOONG PHARMACEUTICAL CO LTD
        1. COMPANY PROFILE
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. EVOLUS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. GALDERMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. HUGEL INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. IPSEN
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. MEDYTOX INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. MERZ PHARMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. REVANCE THERAPEUTICS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      12. US WORLDMEDS LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST

LIST OF TABLES

TABLE 1: NORTH AMERICA MARKET SNAPSHOT – BOTULINUM TOXIN

TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES

TABLE 3: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 4: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 17: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 18: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET

TABLE 19: LIST OF ACQUISITIONS

TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 21: LIST OF PARTNERSHIPS

TABLE 22: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2032 (IN $ MILLION)

FIGURE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022

FIGURE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2032 (IN $ MILLION)

FIGURE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MEN, 2023-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2032 (IN $ MILLION)

FIGURE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022

FIGURE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2032 (IN $ MILLION)

FIGURE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2032 (IN $ MILLION)

FIGURE 17: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2032 (IN $ MILLION)

FIGURE 18: NORTH AMERICA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2032 (IN $ MILLION)

FIGURE 19: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 20: NORTH AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2032 (IN $ MILLION)

FIGURE 21: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022

FIGURE 22: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2032 (IN $ MILLION)

FIGURE 23: NORTH AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2032 (IN $ MILLION)

FIGURE 24: NORTH AMERICA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2032 (IN $ MILLION)

FIGURE 25: NORTH AMERICA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2032 (IN $ MILLION)

FIGURE 26: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 27: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 28: NORTH AMERICA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 29: NORTH AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 30: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)

FIGURE 31: NORTH AMERICA BOTULINUM TOXIN MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 32: UNITED STATES BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FIGURE 33: CANADA BOTULINUM TOXIN MARKET, 2023-2032 (IN $ MILLION)

FAQ’s